Skip to main content
Erschienen in: Clinical Rheumatology 5/2023

04.01.2023 | Original Article

The composition and function profile of the gut microbiota of patients with primary Sjögren’s syndrome

verfasst von: Fang Wang, Yunzhi Zhufeng, Zhe Chen, Jun Xu, Yongjing Cheng

Erschienen in: Clinical Rheumatology | Ausgabe 5/2023

Einloggen, um Zugang zu erhalten

Abstract

Objectives

This healthy volunteer control-based study was conducted to explore alterations of compositions and function of gut microbiota in Chinese pSS patients.

Method

The high-throughput Illumina Miseq sequencing method, targeting the V3-V4 region of the 16S ribosomal RNA (rRNA) gene, was used to compare the microbiota communities between 30 pSS patients and 30 age-matched healthy volunteers. The intestinal dysbiosis of pSS patients was evaluated and its correlation with some disease phenotypes was analyzed. Furthermore, we performed the amino acid sequence alignment analysis to illustrate the molecular mimicry patterns of new microbial peptides.

Results

Compared with that in healthy controls, the composition and function of the gut microbiota significantly differed in pSS patients. Certain genera and species, including genera: Escherichia-Shigella, Sardovia, Veillonella, Insteinimonas, and Lactobacillales; species: Escherichia coli, Lactobacillus phage Sal3, Lactobacillus reuteri, Lactobacillus gasseri, Streptococcus lutetiensis, Streptococcus mutans, Scardovia wiggsiae, and Fusobacterrium ulcerans were found to be enriched in the feces of pSS patients, while butyrate-producing bacteria were less abundant in pSS patients. Certain genera (including Lactobacillales) and species (including Lactobacillus gasseri) were associated with disease severity and therapy resistance parameters. Autoantigen epitopes of “WPSALPT, NPARSFG, MNPARSFG, and AFGLAIGT” from aquaporin-5 were aligned perfectly with one enriched microbiota of patients with pSS, namely Escherichia coli.

Conclusions

The composition and function of the gut microbiota significantly differed in pSS patients compared with that in healthy controls. Our study would facilitate the possible research on the role of gut microbiota in the pathogenesis of pSS.
Key Points
• The composition and function of the gut microbiota significantly differed in pSS patients compared with that in healthy controls.
• Certain genera (including Lactobacillales) and species (including Lactobacillus gasseri) were associated with disease severity and therapy resistance parameters.
• The amino acid sequence of Escherichia coli, an enriched species in pSS patients, is similar to those of the pSS-relevant auto-epitopes, such as WPSALPT, NPARSFG, MNPARSFG, and AFGLAIGT, which provides us new clues to explore the exact mechanisms by which Escherichia coli contributes to pSS pathogenesis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Saraux A, Pers JO, Devauchelle-Pensec V (2016) Treatment of primary Sjogren syndrome. Nat Rev Rheumatol 12(8):456–471CrossRefPubMed Saraux A, Pers JO, Devauchelle-Pensec V (2016) Treatment of primary Sjogren syndrome. Nat Rev Rheumatol 12(8):456–471CrossRefPubMed
2.
Zurück zum Zitat Miossec P, Korn T, Kuchroo VK (2009) Interleukin-17 and type 17 helper T cells. N Engl J Med 361(9):888–898CrossRefPubMed Miossec P, Korn T, Kuchroo VK (2009) Interleukin-17 and type 17 helper T cells. N Engl J Med 361(9):888–898CrossRefPubMed
4.
Zurück zum Zitat Manfrè V, Cafaro G, Riccucci I, Zabotti A, Perricone C, Bootsma H, De Vita S, Bartoloni E (2020) One year in review 2020: comorbidities diagnosis and treatment of primarySjogren’s syndrome.Clin Exp Rheumatol 38 Suppl 126(4):10–22 Manfrè V, Cafaro G, Riccucci I, Zabotti A, Perricone C, Bootsma H, De Vita S, Bartoloni E (2020) One year in review 2020: comorbidities diagnosis and treatment of primarySjogren’s syndrome.Clin Exp Rheumatol 38 Suppl 126(4):10–22
5.
Zurück zum Zitat Björk A, Mofors J, Wahren-Herlenius M (2020) Environmental factors in the pathogenesis of primary Sjogren’s syndrome. J Intern Med 287(5):475–492CrossRefPubMed Björk A, Mofors J, Wahren-Herlenius M (2020) Environmental factors in the pathogenesis of primary Sjogren’s syndrome. J Intern Med 287(5):475–492CrossRefPubMed
6.
Zurück zum Zitat Atarashi K, Tanoue T, Shima T et al (2011) Induction of colonic regulatory T cells by indigenousClostridium species [J]. Science 331:337–341CrossRefPubMed Atarashi K, Tanoue T, Shima T et al (2011) Induction of colonic regulatory T cells by indigenousClostridium species [J]. Science 331:337–341CrossRefPubMed
8.
Zurück zum Zitat Flannigan KL, Denning TL (2018) Segmented filamentous bacteria-induced immune responses: a balancing act between host protection and autoimmunity. Immunology 154(4):537–546CrossRefPubMedPubMedCentral Flannigan KL, Denning TL (2018) Segmented filamentous bacteria-induced immune responses: a balancing act between host protection and autoimmunity. Immunology 154(4):537–546CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Xu M, Pokrovskii M, Ding Y, Yi R, Au C, Harrison OJ, Galan C, Belkaid Y, BonneauR Littman DR (2018) c-MAF-dependent regulatory T cells mediate immunological tolerance to a gut pathobiont. Nature 554(7692):373–377CrossRefPubMedPubMedCentral Xu M, Pokrovskii M, Ding Y, Yi R, Au C, Harrison OJ, Galan C, Belkaid Y, BonneauR Littman DR (2018) c-MAF-dependent regulatory T cells mediate immunological tolerance to a gut pathobiont. Nature 554(7692):373–377CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjogren s syndrome: a revised version of the European criteria proposed by theAmerican-European Consensus Group. Ann Rheum Dis 61:554–558CrossRefPubMedPubMedCentral Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjogren s syndrome: a revised version of the European criteria proposed by theAmerican-European Consensus Group. Ann Rheum Dis 61:554–558CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Seror R, Ravaud P, Bowman SJ et al (2010) EULAR Sjogrens syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren’s syndrome. Ann Rheum Dis 69:1103–1109CrossRefPubMed Seror R, Ravaud P, Bowman SJ et al (2010) EULAR Sjogrens syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren’s syndrome. Ann Rheum Dis 69:1103–1109CrossRefPubMed
13.
Zurück zum Zitat Qian Y, Yang X, Shaoqing Xu, Chunyan Wu, Song Y, Qin N, Chen S-D, Xiao Q (2018) “Alteration of the fecal microbiota in Chinese patients with Parkinson’s disease”, brain, behavior, and immunity. Brain Behav Immun 70:194–202CrossRefPubMed Qian Y, Yang X, Shaoqing Xu, Chunyan Wu, Song Y, Qin N, Chen S-D, Xiao Q (2018) “Alteration of the fecal microbiota in Chinese patients with Parkinson’s disease”, brain, behavior, and immunity. Brain Behav Immun 70:194–202CrossRefPubMed
14.
Zurück zum Zitat Edga R (2013) UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods 10(10):996–8CrossRef Edga R (2013) UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods 10(10):996–8CrossRef
15.
Zurück zum Zitat Yilmaz P, Parfrey LW, Yarza P, Gerken J, Pruesse E, Quast C, Schweer T, Peplies J, Ludwig W, Glöckner FO (2014) The SILVA and “All-species Living Tree Project (LTP)” taxonomic frameworks. Nucleic Acids Res 42(Database issue):D643-8CrossRefPubMed Yilmaz P, Parfrey LW, Yarza P, Gerken J, Pruesse E, Quast C, Schweer T, Peplies J, Ludwig W, Glöckner FO (2014) The SILVA and “All-species Living Tree Project (LTP)” taxonomic frameworks. Nucleic Acids Res 42(Database issue):D643-8CrossRefPubMed
16.
Zurück zum Zitat Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215(3):403–410CrossRefPubMed Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215(3):403–410CrossRefPubMed
17.
Zurück zum Zitat Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R (2010) QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7(5):335–6CrossRefPubMedPubMedCentral Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R (2010) QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7(5):335–6CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215(3):403–410CrossRefPubMed Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215(3):403–410CrossRefPubMed
19.
Zurück zum Zitat de Paiva CS, Jones DB, Stern ME, Bian F, Moore QL, Corbiere S, Streckfus CF, Hutchinson DS, Ajami NJ, Petrosino JF, Pflugfelder SC (2016) Altered mucosal microbiome diversity and disease severity in Sjögren syndrome. Sci Rep 6:23561CrossRefPubMedPubMedCentral de Paiva CS, Jones DB, Stern ME, Bian F, Moore QL, Corbiere S, Streckfus CF, Hutchinson DS, Ajami NJ, Petrosino JF, Pflugfelder SC (2016) Altered mucosal microbiome diversity and disease severity in Sjögren syndrome. Sci Rep 6:23561CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Cano-Ortiz A, Laborda-Illanes A, Plaza-Andrades I, Membrillo Del Pozo A, Villarrubia Cuadrado A, de Rodríguez Calvo Mora M, Leiva-Gea I, Sanchez-Alcoholado L, Queipo-Ortuño MI (2020) Connection between the gut microbiome, systemic inflammation, gut permeability and FOXP3 expression in patients with primary Sjögren’s syndrome. Int J Mol Sci 21(22):8733 CrossRefPubMedPubMedCentral Cano-Ortiz A, Laborda-Illanes A, Plaza-Andrades I, Membrillo Del Pozo A, Villarrubia Cuadrado A, de Rodríguez Calvo Mora M, Leiva-Gea I, Sanchez-Alcoholado L, Queipo-Ortuño MI (2020) Connection between the gut microbiome, systemic inflammation, gut permeability and FOXP3 expression in patients with primary Sjögren’s syndrome. Int J Mol Sci 21(22):8733 CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Zegarra-Ruiz DF, El Beidaq A, Iñiguez AJ, Lubrano Di Ricco M, Manfredo Vieira S, Ruff WE, Mubiru D, Fine RL, Sterpka J, Greiling TM, Dehner C, Kriegel MA (2019) A diet-sensitive commensal lactobacillus strain mediates TLR7-dependent systemic autoimmunity. Cell Host Microbe 25(1):113–127CrossRefPubMed Zegarra-Ruiz DF, El Beidaq A, Iñiguez AJ, Lubrano Di Ricco M, Manfredo Vieira S, Ruff WE, Mubiru D, Fine RL, Sterpka J, Greiling TM, Dehner C, Kriegel MA (2019) A diet-sensitive commensal lactobacillus strain mediates TLR7-dependent systemic autoimmunity. Cell Host Microbe 25(1):113–127CrossRefPubMed
22.
Zurück zum Zitat Xu X, Hicks C, Li Y, Su J, Shiloach J, Kaufman JB, Fitz Y, Eichacker PQ, Cui X (2014) Purified cell wall from the probiotic bacterium Lactobacillus gasseri activates systemic inflammation and at higher doses, produces lethality in a rat model. Crit Care 18(4):R140CrossRefPubMedPubMedCentral Xu X, Hicks C, Li Y, Su J, Shiloach J, Kaufman JB, Fitz Y, Eichacker PQ, Cui X (2014) Purified cell wall from the probiotic bacterium Lactobacillus gasseri activates systemic inflammation and at higher doses, produces lethality in a rat model. Crit Care 18(4):R140CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Tochio T, Kadota Y, Tanaka T, Koga Y (2018) 1-Kestose, the smallest fructooligosaccharide component, which efficiently stimulates Faecalibacterium prausnitzii as well as bifidobacteria in humans. Foods 7(9):140CrossRefPubMedPubMedCentral Tochio T, Kadota Y, Tanaka T, Koga Y (2018) 1-Kestose, the smallest fructooligosaccharide component, which efficiently stimulates Faecalibacterium prausnitzii as well as bifidobacteria in humans. Foods 7(9):140CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Zhao H, Xu H, Chen S, He J, Zhou Y, Nie Y (2021) Systematic review and meta-analysis of the role of Faecalibacterium prausnitzii alteration in inflammatory bowel disease. J Gastroenterol Hepatol 6(2):320–328 Zhao H, Xu H, Chen S, He J, Zhou Y, Nie Y (2021) Systematic review and meta-analysis of the role of Faecalibacterium prausnitzii alteration in inflammatory bowel disease. J Gastroenterol Hepatol 6(2):320–328
25.
Zurück zum Zitat Hiippala K, Barreto G, Burrello C, Diaz-Basabe A, Suutarinen M, Kainulainen V, Bowers JR, Lemmer D, Engelthaler DM, Eklund KK, Facciotti F, Satokari R (2020) Novel Odoribacter splanchnicus Strain and its outer membrane vesicles exert immunoregulatory effects in vitro. Front Microbiol 11:575455CrossRefPubMedPubMedCentral Hiippala K, Barreto G, Burrello C, Diaz-Basabe A, Suutarinen M, Kainulainen V, Bowers JR, Lemmer D, Engelthaler DM, Eklund KK, Facciotti F, Satokari R (2020) Novel Odoribacter splanchnicus Strain and its outer membrane vesicles exert immunoregulatory effects in vitro. Front Microbiol 11:575455CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Nylund L, Nermes M, Isolauri E, Salminen S, de Vos WM, Satokari R (2015Feb) Severity of atopic disease inversely correlates with intestinal microbiota diversity and butyrate-producing bacteria. Allergy 70(2):241–244CrossRefPubMed Nylund L, Nermes M, Isolauri E, Salminen S, de Vos WM, Satokari R (2015Feb) Severity of atopic disease inversely correlates with intestinal microbiota diversity and butyrate-producing bacteria. Allergy 70(2):241–244CrossRefPubMed
27.
Zurück zum Zitat Yanagisawa N, Ueshiba H, Abe Y, Kato H, Higuchi T, Yagi J (2018) Outer membrane protein of gut commensal microorganism induces autoantibody production and extra-intestinal gland inflammation in mice. Int J Mol Sci 19(10):3241CrossRefPubMedPubMedCentral Yanagisawa N, Ueshiba H, Abe Y, Kato H, Higuchi T, Yagi J (2018) Outer membrane protein of gut commensal microorganism induces autoantibody production and extra-intestinal gland inflammation in mice. Int J Mol Sci 19(10):3241CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Winter SE, Winter MG, Xavier MN, Thiennimitr P, Poon V, Keestra AM, Laughlin RC, Gomez G, Wu J, Lawhon SD, Popova IE, Parikh SJ, Adams LG, Tsolis RM, Stewart VJ, Bäumler AJ (2013) Host-derived nitrate boosts growth of E coli in the inflamed gut. Science 339(6120):708–11CrossRefPubMedPubMedCentral Winter SE, Winter MG, Xavier MN, Thiennimitr P, Poon V, Keestra AM, Laughlin RC, Gomez G, Wu J, Lawhon SD, Popova IE, Parikh SJ, Adams LG, Tsolis RM, Stewart VJ, Bäumler AJ (2013) Host-derived nitrate boosts growth of E coli in the inflamed gut. Science 339(6120):708–11CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Yanagisawa N, Ueshiba H, Abe Y, Kato H, Higuchi T, Yagi J (2018) Outer membrane protein of gut commensal microorganism induces autoantibody production and extra-intestinal gland inflammation in mice. Int J Mol Sci 19(10):3241CrossRefPubMedPubMedCentral Yanagisawa N, Ueshiba H, Abe Y, Kato H, Higuchi T, Yagi J (2018) Outer membrane protein of gut commensal microorganism induces autoantibody production and extra-intestinal gland inflammation in mice. Int J Mol Sci 19(10):3241CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Chen BD, Jia XM, Xu JY, Zhao LD, Ji JY, Wu BX, Ma Y, Li H, Zuo XX, Pan WY, Wang XH, Ye S, Tsokos GC, Wang J, Zhang X (2021) An autoimmunogenic and proinflammatory profile defined by the gut microbiota of patients with untreated systemic Lupus Erythematosus. Arthritis Rheumatol 73(2):232–243CrossRefPubMed Chen BD, Jia XM, Xu JY, Zhao LD, Ji JY, Wu BX, Ma Y, Li H, Zuo XX, Pan WY, Wang XH, Ye S, Tsokos GC, Wang J, Zhang X (2021) An autoimmunogenic and proinflammatory profile defined by the gut microbiota of patients with untreated systemic Lupus Erythematosus. Arthritis Rheumatol 73(2):232–243CrossRefPubMed
Metadaten
Titel
The composition and function profile of the gut microbiota of patients with primary Sjögren’s syndrome
verfasst von
Fang Wang
Yunzhi Zhufeng
Zhe Chen
Jun Xu
Yongjing Cheng
Publikationsdatum
04.01.2023
Verlag
Springer International Publishing
Erschienen in
Clinical Rheumatology / Ausgabe 5/2023
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-022-06451-1

Weitere Artikel der Ausgabe 5/2023

Clinical Rheumatology 5/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.